79 related articles for article (PubMed ID: 23830897)
21. Evaluation of transcriptomic signature as a valuable tool to study drug-induced cholestasis in primary human hepatocytes.
Parmentier C; Couttet P; Wolf A; Zaccharias T; Heyd B; Bachellier P; Uteng M; Richert L
Arch Toxicol; 2017 Aug; 91(8):2879-2893. PubMed ID: 28188341
[TBL] [Abstract][Full Text] [Related]
22. [Serum bile acids in the newborn: our experience].
Pifferí M; Michelotti F; Domenici R; Fiorini V; Michelotti F; Ceccarelli M
Pediatr Med Chir; 1990; 12(3):251-4. PubMed ID: 2274436
[TBL] [Abstract][Full Text] [Related]
23. Identification of urinary biomarkers useful for distinguishing a difference in mechanism of toxicity in rat model of cholestasis.
Ishihara K; Katsutani N; Asai N; Inomata A; Uemura Y; Suganuma A; Sawada K; Yokoi T; Aoki T
Basic Clin Pharmacol Toxicol; 2009 Sep; 105(3):156-66. PubMed ID: 19486331
[TBL] [Abstract][Full Text] [Related]
24. Effect of cyclosporin A in vivo on taurocholate uptake by rat hepatocytes.
Azer SA; Stacey NH
Biochem Pharmacol; 1991 Oct; 42(10):2053-7. PubMed ID: 1741783
[No Abstract] [Full Text] [Related]
25. Analysis of liver function in renal transplant recipients undergoing C2-monitoring for cyclosporine.
Hecking M; Kainz A; Schillinger M; Posch C; Birsan T; Rasoul-Rockenschaub S; Böhmig GA; Schmaldienst S; Watschinger B; Hörl WH; Mühlbacher F; Säemann MD
Transpl Int; 2008 Mar; 21(3):223-33. PubMed ID: 17903183
[TBL] [Abstract][Full Text] [Related]
26. Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity.
Higuchi H; Bronk SF; Taniai M; Canbay A; Gores GJ
J Pharmacol Exp Ther; 2002 Nov; 303(2):461-7. PubMed ID: 12388624
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity of HPLC and conventional bilirubin measurements in the detection of early cholestasis.
Pieper-Bigelow C; Eckfeldt J; Levitt MD
J Lab Clin Med; 1995 May; 125(5):654-61. PubMed ID: 7738430
[TBL] [Abstract][Full Text] [Related]
28. Serum bile acids in cholestasis of pregnancy.
Laatikainen T; Ikonen E
Obstet Gynecol; 1977 Sep; 50(3):313-8. PubMed ID: 896101
[TBL] [Abstract][Full Text] [Related]
29. Screening for drug-induced hepatotoxicity in primary mouse hepatocytes using acetaminophen, amiodarone, and cyclosporin a as model compounds: an omics-guided approach.
Van Summeren A; Renes J; Lizarraga D; Bouwman FG; Noben JP; van Delft JH; Kleinjans JC; Mariman EC
OMICS; 2013 Feb; 17(2):71-83. PubMed ID: 23308384
[TBL] [Abstract][Full Text] [Related]
30. Inter-laboratory comparison of human renal proximal tubule (HK-2) transcriptome alterations due to Cyclosporine A exposure and medium exhaustion.
Jennings P; Aydin S; Bennett J; McBride R; Weiland C; Tuite N; Gruber LN; Perco P; Gaora PO; Ellinger-Ziegelbauer H; Ahr HJ; Kooten CV; Daha MR; Prieto P; Ryan MP; Pfaller W; McMorrow T
Toxicol In Vitro; 2009 Apr; 23(3):486-99. PubMed ID: 19159671
[TBL] [Abstract][Full Text] [Related]
31. Factors producing bile infarction and bile duct proliferation in biliary obstruction.
Shibayama Y
J Pathol; 1990 Jan; 160(1):57-62. PubMed ID: 2313481
[TBL] [Abstract][Full Text] [Related]
32. Platycodin D attenuates bile duct ligation-induced hepatic injury and fibrosis in mice.
Kim TW; Lee HK; Song IB; Lim JH; Cho ES; Son HY; Jung JY; Yun HI
Food Chem Toxicol; 2013 Jan; 51():364-9. PubMed ID: 23116642
[TBL] [Abstract][Full Text] [Related]
33. Toluene-induced elevation of serum bile acids: relationship to bile acid transport.
Neghab M; Stacey NH
J Toxicol Environ Health; 1997 Oct; 52(3):249-68. PubMed ID: 9316646
[TBL] [Abstract][Full Text] [Related]
34. Hematologic and biochemical abnormalities associated with induced extrahepatic bile duct obstruction in the cat.
Center SA; Baldwin BH; King JM; Tennant BC
Am J Vet Res; 1983 Oct; 44(10):1822-9. PubMed ID: 6638641
[TBL] [Abstract][Full Text] [Related]
35. Validation of precision-cut liver slices to study drug-induced cholestasis: a transcriptomics approach.
Vatakuti S; Olinga P; Pennings JLA; Groothuis GMM
Arch Toxicol; 2017 Mar; 91(3):1401-1412. PubMed ID: 27344345
[TBL] [Abstract][Full Text] [Related]
36. Development of an approach for ab initio estimation of compound-induced liver injury based on global gene transcriptional profiles.
Dai X; He YD; Dai H; Lum PY; Roberts CJ; Waring JF; Ulrich RG
Genome Inform; 2006; 17(2):77-88. PubMed ID: 17503381
[TBL] [Abstract][Full Text] [Related]
37. Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes.
Oorts M; Baze A; Bachellier P; Heyd B; Zacharias T; Annaert P; Richert L
Toxicol In Vitro; 2016 Aug; 34():179-186. PubMed ID: 27046439
[TBL] [Abstract][Full Text] [Related]
38. Differential proteomic analysis of cyclosporine A-induced toxicity in renal proximal tubule cells.
Puigmulé M; López-Hellin J; Suñé G; Tornavaca O; Camaño S; Tejedor A; Meseguer A
Nephrol Dial Transplant; 2009 Sep; 24(9):2672-86. PubMed ID: 19369687
[TBL] [Abstract][Full Text] [Related]
39. Cyclosporin A decreases the degradation of type I collagen in rat gingival overgrowth.
Kataoka M; Shimizu Y; Kunikiyo K; Asahara Y; Yamashita K; Ninomiya M; Morisaki I; Ohsaki Y; Kido JI; Nagata T
J Cell Physiol; 2000 Mar; 182(3):351-8. PubMed ID: 10653601
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of cyclosporin A on transport of bile acids by rat hepatocytes: relationship to individual serum bile acid levels.
Azer SA; Stacey NH
Toxicol Appl Pharmacol; 1994 Feb; 124(2):302-9. PubMed ID: 8122277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
